|
RRP1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.364260E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.480800E-03 |
| Normal-vs-Stage2 |
8.719600E-01 |
| Normal-vs-Stage3 |
9.529700E-02 |
| Normal-vs-Stage4 |
9.513500E-02 |
| Stage1-vs-Stage2 |
4.661800E-02 |
| Stage1-vs-Stage3 |
5.177800E-01 |
| Stage1-vs-Stage4 |
4.994000E-01 |
| Stage2-vs-Stage3 |
1.917040E-01 |
| Stage2-vs-Stage4 |
1.986360E-01 |
| Stage3-vs-Stage4 |
9.767800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.860700E-03 |
| Normal-vs-AfricanAmerican |
5.871200E-01 |
| Normal-vs-Asian |
2.677400E-01 |
| Caucasian-vs-AfricanAmerican |
3.394200E-01 |
| Caucasian-vs-Asian |
9.046200E-01 |
| AfricanAmerican-vs-Asian |
6.446600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.500100E-02 |
| Normal-vs-Female |
1.984220E-02 |
| Male-vs-Female |
7.695200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.193000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.452300E-02 |
| Normal-vs-Age(61-80Yrs) |
9.516900E-03 |
| Normal-vs-Age(81-100Yrs) |
9.477600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.758800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.748800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.191200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.140200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.443200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.910980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.645600E-02 |
| Normal-vs-Grade 2 |
6.063100E-03 |
| Normal-vs-Grade 3 |
1.212030E-01 |
| Normal-vs-Grade 4 |
1.019390E-01 |
| Grade 1-vs-Grade 2 |
8.630200E-01 |
| Grade 1-vs-Grade 3 |
5.668000E-01 |
| Grade 1-vs-Grade 4 |
6.594000E-01 |
| Grade 2-vs-Grade 3 |
1.691810E-01 |
| Grade 2-vs-Grade 4 |
4.964000E-01 |
| Grade 3-vs-Grade 4 |
7.186000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.201000E-03 |
| Normal-vs-ccB subtype |
4.844500E-02 |
| ccA subtype-vs-ccB subtype |
6.712200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.392100E-02 |
| Normal-vs-N1 |
1.176180E-01 |
| N0-vs-N1 |
2.655400E-01 |
|
|
